Skip to content

Cognitive rehabilitation in brain tumor patients after neurosurgery

Cognitive rehabilitation in brain tumor patients after neurosurgery - COG REHAB brain tumor patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON44894
Enrollment
150
Registered
2014-12-31
Start date
2015-10-30
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitieve stoornissen Cognitive deficits memory and attention problems

Interventions

A tablet app based on our previously evaluated cognitive rehabilitation program will be used as intervention to improve cognitive functioning. The program is aimed at both retraining and teaching of

Sponsors

Sint Elisabeth Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * The patient has a brain tumor that is radiologically suspect for either a meningioma or low grade glioma. * The patient will undergo craniotomy for the brain tumor. * The patient is in clinical reasonable or good condition (Karnovsky performance Scale >

Exclusion criteria

Exclusion criteria: Resection of the tumor in the last year, comorbid neurodegenerative disease, psychiatric or neurological disorder in the last 2 years, chemotherapy in the last 2 years, lack of basic proficiency in Dutch, IQ below 85, or (very) low cognitive skills, Karnovsky Performance Scale under 70, complete unfamiliarity with the use of computers, surgery-related complication (morbidity or mortality e.g., thrombosis or heart attack), and insufficient reading skills (limiting the ability to follow the cognitive rehabilitation program) and cognitive rehabilitation elsewhere.

Design outcomes

Primary

MeasureTime frame
Feasibility (adherence, patient experience, attrition) will be monitored in the feasibility study. Cognitive functioning: group and individual neuropsychological performance, as assessed with the computerized battery of neuropsychological tests and the two additional neuropsychological tests, at the 3 months*, 6 months' and 12 months* assessment as compared to baseline, and magnitude of change over time.

Secondary

MeasureTime frame
Self-reported symptoms/functioning: self-reported cognitive functioning, psychological symptoms (anxiety and depression), and fatigue as assessed with questionnaires at the 3, 6 and 12 months* assessment; professional functioning and community integration as assessed with questionnaires at the 12 months* assessment; self-reported and informant-reported executive functioning as assessed with a questionnaire at the 3 and 6 months' assessment.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)